ALBT - Avalon GloboCare Corp.
3.895
0.145 3.723%
Share volume: 19,998
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.75
0.15
0.04%
Summary score
15%
Profitability
0%
Dept financing
25%
Liquidity
1%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-13.99%
Return on sales
-829.79%
Return on invested capital
0%
Total debt ratio
115.76%
Debt ratio change over timeo
0%
Current Ratio
0.31%
Quick Ratio
0%
Cash Position Ratio
0.23%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-16.67%
Return on sales
-1058.23%
Return on invested capital
0%
Total debt ratio
171.12%
Debt ratio change over timeo
0%
Current Ratio
0.11%
Quick Ratio
0%
Cash Position Ratio
0.05%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-5.79%
Return on sales
-367.94%
Return on invested capital
0%
Total debt ratio
174.67%
Debt ratio change over time
0%
Current Ratio
0.11%
Quick Ratio
0%
Cash Position Ratio
0.08%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALBT | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.34% | 6.69% | 16.49% |
| Return on assets | -13.99% | 3.17% | 3.1% | 15.3% |
| Return on sales | -829.79% | 30.73% | 28.93% | 7.81% |
| Return on invested capital | 0% | 5.33% | 3.55% | -56.8% |
| Profitability | 0% | 80% | 54% | 54% |
| Total debt ratio | 115.76% | 91.7% | 67.67% | 20.78% |
| Debt ratio change over time | 0% | 20.48% | 127.93% | -1.07% |
| Dept financing | 25% | 24% | 40% | 4% |
| Current Ratio | 0.11% | 1.41% | 1.23% | 10.4% |
| Quick Ratio | 0% | 0.99% | 1.06% | 10.21% |
| Cash Position Ratio | 0.05% | 0.49% | 0.42% | 5.61% |
| Liquididy | 3% | 18% | 13% | 75% |
| Short-term ratios | ALBT | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 6.26% | 0.37% |
| Return on assets | -16.67% | 2.14% | 0.55% | 0.13% |
| Return on sales | -1058.23% | 18.91% | 3.35% | -117.21% |
| Return on invested capital | 0% | 0% | 4.11% | 10% |
| Profitability | 0% | 50% | 46% | 28% |
| Total debt ratio | 171.12% | 93.35% | 66.02% | 11.14% |
| Debt ratio change over time | 0% | 0% | 12.37% | -0.23% |
| Dept financing | 25% | 14% | 35% | 2% |
| Current Ratio | 0.11% | 1.41% | 1.23% | 10.4% |
| Quick Ratio | 0% | 0.99% | 1.06% | 10.21% |
| Cash Position Ratio | 0.05% | 0.49% | 0.42% | 5.61% |
| Liquididy | 0% | 8% | 7% | 75% |
